Marksans Pharma Ltd

NSE: MARKSANS · BSE: 524404 · Pharmaceuticals & Biotechnology · 37 announcements

Share price: ₹306.55
Market cap: ₹13,893 Cr
Revenue (annual): ₹2,951 Cr
Net profit (annual): ₹417.9 Cr
P/E (TTM): 24.8×Sector 43.8×
Promoter holding: 43.87%+0.00% QoQ
FII holding: 19.06%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 8 Other Announcement 5 Financial Results 4 Board Meeting Date 3 Acquisition 3 Results Update 2 Merger & Restructuring 2 Employee Stock Options 2 Annual General Meeting 2 Promoter Selling (Off-Market) 1 Dividend 1 Credit Rating 1 Business Update 1 Board Meeting Outcome 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

4 Nov 2026 13:42 IST NSE

Results Update

Marksans Pharma Results Update

Marksans Pharma reported Q2FY27 revenue of ₹940 crore and H1FY27 PAT of ₹303 crore. EBITDA grew 48% to a record ₹214 crore in the quarter.

Open announcement → Read the filing ↗

26 May 2026 13:30 IST BSE

Results Update

Marksans Pharma Results Update

Marksans Pharma reported a record FY26 total income of ₹3,033.5 Crore, up 12.8% YoY. The company achieved historic highs in revenue, EBITDA, and PAT during the year.

Value: ₹3,034 Cr

Open announcement → Read the filing ↗